Conference Programme

Maximising Returns from Life Science Innovation

4 December 2024

Maximising Returns from Life Science Innovation

Programme

The 2024 Keynote Programme at Genesis will explore the exciting potential offered by innovation in life sciences offers to address global health, economic and sustainability challenges. Whilst the sessions will also discuss how the barriers to progress can be defeated through creative thinking in R&D, collaboration, investment, and patient access to translate the golden triangle of ‘technology-people-money’ into creation for all stakeholders.

.

Registration

Welcome from One Nucleus

Keynote Address: tbc

With the US seen as the key market for UK life science companies and international VCs contributing the majority of the essential growth investment for UK biotechs (US > 30% in 2023), what’s happening in the global money markets and what does that mean for Life Sciences?

Panel: Mansion or Maisonette?  

With UK Government backing policies to enable Life Sciences to a key driver of economic growth, including pension reforms, tech transfer support and R&D tax incentives, what is a realistic aspiration for the sector.  

Coffee Break

Keynote Address: Winner & Losers 2024

Panel: What Happens After the Deal is Signed?

Discussions about the art of dealmaking normally focus on the partner search, the courtship dance, negotiation, due diligence and finally the deal getting signed. Yet in many ways, that is just the start. How should the dealmaking parties interact post-deal to maximise the value creation going forward? 

Fireside Chat: A Patient’s Perspective of the Life Science Industry

Collectively and as individuals, the attraction of working in the Life Sciences industry is grounded in the desire to further knowledge and translation of innovation into products and services that improve patients’ lives. How does our industry look from the patient’s perspective?

Lunch

Panel: Why My Technology Would Appear Cheap at Twice the Price?

Valuation is one of the most debated elements of any deal or transaction. This panel will discuss
(i) how the innovator should create and defend their proposed valuation
(ii) how the investor or buyer assesses the innovator’s homework
(iii) how do you know when to sign or walk away?

Keynote Address: Introducing Disruptive Technologies: Lessons from a Passionate Entrepreneur

Panel: Watch This Space?

With the pace of change increasing, sector commentators will discuss what they are most looking forward to writing about in the coming year.

Coffee Break

Keynote Address: tbc

Panel: Biology and Technology – Where Do You Fit and Who Does it Matter To?

With the explosion new terminology to describe the science of living things, such as Biotech, TechBio, Deep Biotech, Agri-Tech and HealthTech this panel will discuss where companies find their sense of identity when developing their value proposition.

One Nucleus in 2025

Panel: Inside the Mind of a Life Science Investor

How much of investment decision-making is an art and how much is science? This panel of investment leaders will discuss their approach to selecting the right deals.

Closing Remarks

Tony Jones, One Nucleus

Drinks Reception

Close

Programme is subject to change